Indications and Purposes
| 1 Indications And Usage Synribo Is Indicated For The Treatment Of Adult Patients With Chronic Or Accelerated Phase Chronic Myeloid Leukemia (Cml) With Resistance And/or Intolerance To Two Or More Tyrosine Kinase Inhibitors (Tki). Synribo For Injection Is Indicated For The Treatment Of Adult Patients With Chronic Or Accelerated Phase Chronic Myeloid Leukemia (Cml) With Resistance And/or Intolerance To Two Or More Tyrosine Kinase Inhibitors (Tki) ( 1 ). |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Omacetaxine Mepesuccinate |